Thymopoietin II: 32-35

Suppliers

Names

[ CAS No. ]:
85466-18-8

[ Name ]:
Thymopoietin II: 32-35

[Synonym ]:
Rgh 0206
Thymocartina [INN-Spanish]
Thymocartine [INN-French]
Thymocartinum [INN-Latin]
Thymocartina
Thymocartin
Thymopoietin II: 32-35

Chemical & Physical Properties

[ Density]:
1.45g/cm3

[ Molecular Formula ]:
C21H40N8O7

[ Molecular Weight ]:
516.59200

[ Exact Mass ]:
516.30200

[ PSA ]:
275.84000

[ LogP ]:
1.13990

[ Index of Refraction ]:
1.619

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YV9384000
CHEMICAL NAME :
L-Valine, N-(N-(N(sup 2)-L-arginyl-L-lysyl)-L-alpha-aspartyl)-
CAS REGISTRY NUMBER :
85466-18-8
LAST UPDATED :
199410
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C21-H40-N8-O7
MOLECULAR WEIGHT :
516.69

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986

Related Compounds

  • Thymopoietin II: 32-34
  • BETA-AMYLOID (32-35)
  • 1,6,11,18,32,35,42,56-octa-(pentafluoroethyl)-[60]fullerene
  • 1-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-tridecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]tridecane
  • 2,21-dithia-7,10,13,16,26,29,32,35-octaazaheptacyclo[34.2.2.2~3,6~.2~10,13~.2~17,20~.2~22,25~.2~29,32~]pentaconta-1(38),3,5,17,19,22,24,36,39,43,45,49-dodecaene-8,15,27,34-tetrone 2,2,21,21-tetraoxide
  • 2,5,8,11,14,17,20,23,26,29,32,35-Dodecaoxaheptatriacontan-37-amine
  • 2-phenoxy-N-(2-{[1-(prop-2-yn-1-yl)piperidin-4-yl]formamido}ethyl)acetamide
  • 8-(4-Methoxyphenyl)-2,8-diazaspiro[4.5]decane
  • n-(Tert-butyl)-1-isobutyl-5-oxopyrrolidine-3-carboxamide
  • N-{2-[(4-nitrophenyl)amino]ethyl}-1-(prop-2-yn-1-yl)piperidine-4-carboxamide
  • n-(Tert-butyl)-1-(cyclopropylmethyl)-5-oxopyrrolidine-3-carboxamide
  • 2-tert-butyl-1H-pyrrolo[3,2-b]pyridin-5-amine
  • N-(1-cyano-1-cyclopropylethyl)-2-(3-methanesulfonylphenoxy)acetamide
  • 5-cyclopropyl-N-[2-(morpholin-4-yl)-2-(thiophen-2-yl)ethyl]-1,2-oxazole-3-carboxamide
  • N-methyl-3-oxo-N-(propan-2-yl)piperazine-1-sulfonamide
  • N-benzyl-N-(2-hydroxyethyl)cyclobutanecarboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.